EquitiesIndia.com

Healthcare · Drug Manufacturers - Specialty & Generic

Torrent Pharmaceuticals Ltd.

TORNTPHARM

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Limited.

NSE: TORNTPHARMOfficial website ↗

Key metrics

Market Cap

₹1.41 lakh cr

P/E Ratio

61.73x

P/B Ratio

18.53x

ROE

25.18%

ROCE

27.09%

Debt / Equity

0.42x

Net Margin

16.89%

Dividend Yield

84%

EPS

₹56.47

Period

FY2025

Shareholding pattern

As of Latest
Promoter: 71.13%FII: 14.86%Public: 14.01%

Deep-dive pages

Educational content — not investment adviceThis page presents publicly available information about Torrent Pharmaceuticals Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.